UPTAKE - Virtual Care: Virtual Home Hospital With Remote Monitoring to Reduce Acute Care Hospitalization

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Calgary

About this trial

Method: Randomized Controlled Trial Study Duration: 3 Years Study Centre(s) University of Calgary and University of Alberta Objectives: To fill care gaps by implementing strategies to reduce length of hospital stay, readmission rates, and improve long-term outcomes after Acute Kidney Injury (AKI). Number of Participants: Three Hundred and fifty four (n=354) Diagnosis and Main Inclusion Criteria: Hospitalized adults with AKI at high risk of hospital readmission or death

Study Intervention: Multi-component Digital Health Solutions, including:

1. Computerized Clinical Decision Support (CDS) and 2. Virtual Care Delivered through Hospital at Home (VC) Duration of administration: Determined by the Patient's clinical team Reference therapy: Usual Care Statistical Analyses: Descriptive Analysis, Regression

Eligibility criteria

Qualifiers

Age ≥ 18 years old.

AKI identified in hospital using Kidney Disease Improving Global Outcomes (KDIGO) criteria17.

Hospitalization > 48 hours.

LACE (L= Length patient Stay in the hospital, A= Acuity of Admission of patient in the hospital, C= Comorbidity and E= Emergency Visit.) Score 12 or higher.

Disqualifiers

Non-Alberta residents.

Resides outside the catchment areas for the Calgary and Edmonton Virtual Home Hospital programs.

C1 or C2 goals of care.

Hospitalization > 30 days.

Trial design

Treatments tested in this trial

  • Virtual Care

Treatment groups

354 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Calgary

Lead sponsor

Alberta Health services

Collaborator